December 03, 2024 at 2:26 pm

Texas: Pioneering the Future of Green Hydrogen Production

Texas stands at the forefront of a potential energy revolution, positioning itself as a key player in the production of green hydrogen. This promising clean energy source is generated through electrolysis, a process that separates water into hydrogen and oxygen, all while avoiding harmful carbon emissions. A recent study published in the Proceedings of the National… [Read More]
December 03, 2024 at 1:24 pm

South Korean President Declares Martial Law as Won Drops to Two-Year Low

South Korean President Yoon Suk Yeol declared emergency martial law in a surprise national address late Tuesday, citing the need to combat pro-North Korean forces and protect freedom and constitutional order. He accused the opposition of engaging in anti-state activities, including attempts to paralyze the administration with impeachment efforts. The last time South Korea’s president… [Read More]
December 03, 2024 at 10:45 am

Applied Therapeutics Charts Path Forward After FDA Setback, Eyes European Approval and Pipeline Expansion

Applied Therapeutics (NASDAQ: APLT) received a warning letter from the FDA concerning its study of govorestat, a drug intended to treat the rare genetic disease galactosemia. This follows last week’s FDA rejection of the drug’s marketing application, citing deficiencies. The warning letter identifies issues with electronic data capture and a dosing error during the trial’s… [Read More]
December 03, 2024 at 10:28 am

Janux Therapeutics Surges Over 60% on Promising Prostate Cancer Drug Results

Janux Therapeutics (NASDAQ: JANX) reported groundbreaking results from its trial of a new drug for heavily pretreated patients with metastatic prostate cancer. After 12 weeks of treatment, all 16 participants experienced at least a 50% decline in prostate-specific antigen (PSA) levels, a key marker for prostate cancer. Key Findings: Significant PSA Reductions: 10 out of… [Read More]
December 02, 2024 at 1:45 pm

PRISM NextGen Tech & AI: Spectral AI Achieves Key Milestone in AI-Driven Wound Care Diagnostics

Spectral AI (Nasdaq: MDAI), an AI-focused company transforming medical diagnostics for improved wound care, announced the successful completion of “truthing” for all burn center images collected across the U.S. This achievement marks a critical step in training the company’s proprietary DeepView® System to accurately predict wound healing outcomes. Building on this milestone, Spectral AI has… [Read More]
December 02, 2024 at 1:34 pm

Delcath Systems Green-Lit by FDA for Phase 2 Trial in Liver-Dominant Metastatic Colorectal Cancer

Delcath Systems, Inc. (NASDAQ: DCTH), a company specializing in interventional oncology, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase 2 clinical trial evaluating HEPZATO™ in combination with standard of care (SOC) treatments for liver-dominant metastatic colorectal cancer (mCRC). With this clearance, the company… [Read More]
December 02, 2024 at 1:24 pm

Nissan’s Fight for Survival: Leadership Shifts, Cost Cuts, and the Battle Against Cheaper EVs

Nissan, the Japanese automotive giant, is grappling with significant financial and operational challenges as it confronts a rapidly shifting global auto market. The company recently announced plans to cut 9,000 jobs, reduce production capacity by 20%, and streamline operations in an effort to save $2.6 billion in the current fiscal year. This comes amid declining… [Read More]
December 02, 2024 at 11:42 am

Promise For Cyber Monday? Black Friday Online Sales Shine, In-Store Traffic Struggles

Black Friday shopping trends underscored a continued shift in consumer behavior, with online sales outperforming in-store traffic. While the broader US consumer landscape remains resilient, supported by a strong labor market, higher asset prices, and lingering savings, challenges such as inflation, higher interest rates, and post-pandemic adjustments persist. However, some key takeaways and trends from… [Read More]
December 02, 2024 at 11:22 am

The First Hearing Commences Today on DEA Marijuana Rescheduling

Today marks the beginning of the Drug Enforcement Administration’s (DEA) first hearing on the Biden administration’s proposal to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). This initial session can be watched live here and is largely procedural, setting the stage for more detailed hearings anticipated next year. At… [Read More]